This website contains promotional content and is intended for Healthcare Professionals in the Republic of Ireland only. Adverse event reporting can be found at the bottom of the page
{ event: "article_read", name: `Diabetes UK 2024: Navigating Hyperglycaemia after GLP-1s with Insulin`, author: `Bethany Kelly`, tags: ``, publication_date: ``, interaction_type: "content" }
Article
Source: Campus Sanofi
Diabetes UK 2024: Navigating Hyperglycaemia after GLP-1s with Insulin
Author :Bethany Kelly
Editorial team
Diabetes UK 2024 - in collaboration with Diabetes Specialist Nurse Forum UK
Prescribing information is available by clicking the links at the bottom of the page
Diabetes Nurse Beth Kelly shares how to navigate hyperglycaemia after GLP-1s with insulin. She shares Toujeo® (insulin glargine 300 units/ml) data and a case study.
You are going to a website that is not operated by Sanofi or a Sanofi website where the terms of use may differ. For external websites, Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party or Sanofi sites.
This site is intended for Healthcare Professionals in the Republic of Ireland and contains information on Sanofi Ireland medicine, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a Healthcare Professional in the Republic of Ireland. This site contains promotional information.
.jpg/jcr:content.jpg){kind=logo}
